Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris ISIN: FR0014005I80 / Ticker: ALSMA...
SMAIO first-half 2023 sales at €4.0m, excluding intra-group1 transactions, up a sustained +203% thanks to NuVasive milestone payment of $3m...
Très forte progression à l’international portée par le paiement d’étape de 3 M$ (environ 2,8 M€) de la part de NuVasive Solide trésorerie de 7,3...
Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, Code ISIN : FR0014005I80 / Mnémonique...
€1.0m through a Bpifrance Innovation R&D loan with a 3-year grace period €1.5m through loans from BNP Paribas and Société Générale...
2022 sales up +15% to €2.4 million driven by international business Significant improvement in the margin on cost of sales to 63% from 55% in...
Fort développement des ventes à l’international en croissance de +60% Interview vidéo : Philippe Roussouly, Président directeur général de...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.